{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T22:37:07Z","timestamp":1791844627550,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100019018","name":"CAMS Innovation Fund for Medical Sciences","doi-asserted-by":"publisher","award":["2021-I2M-1037"],"award-info":[{"award-number":["2021-I2M-1037"]}],"id":[{"id":"10.13039\/501100019018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003345","name":"Chinese Academy of Meteorological Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003345","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004826","name":"Natural Science Foundation of Beijing Municipality","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82230076"],"award-info":[{"award-number":["82230076"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.micinf.2024.105366","type":"journal-article","created":{"date-parts":[[2024,5,20]],"date-time":"2024-05-20T22:00:34Z","timestamp":1716242434000},"page":"105366","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure"],"prefix":"10.1016","volume":"26","author":[{"given":"Xiuzhu","family":"Geng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanmei","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihui","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxian","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2024.105366_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.coviro.2021.07.005","article-title":"HIV-1 entry: duels between Env and host antiviral transmembrane proteins on the surface of virus particles","volume":"50","author":"Murakami","year":"2021","journal-title":"Curr Opin Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib2","doi-asserted-by":"crossref","first-page":"735","DOI":"10.3390\/v13050735","article-title":"HIV-1 entry and membrane fusion inhibitors","volume":"13","author":"Xiao","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2024.105366_bib3","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.2174\/1381612811319100004","article-title":"Synthesized peptide inhibitors of HIV-1 gp41-dependent membrane fusion","volume":"19","author":"He","year":"2013","journal-title":"Curr Pharmaceut Des"},{"key":"10.1016\/j.micinf.2024.105366_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0092-8674(00)80066-5","article-title":"Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket","volume":"99","author":"Eckert","year":"1999","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2024.105366_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0092-8674(00)81430-0","article-title":"HIV entry and its inhibition","volume":"93","author":"Chan","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2024.105366_bib6","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1056\/NEJM200310303491815","article-title":"Enfuvirtide, an HIV-1 fusion inhibitor","volume":"349","author":"Carr","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2024.105366_bib7","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1056\/NEJMoa035211","article-title":"Efficacy of enfuvirtide in patients infected with drug-resistant HIV-1 in Europe and Australia","volume":"348","author":"Lazzarin","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2024.105366_bib8","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1056\/NEJMoa035026","article-title":"Enfuvirtide, an HIV-1 fusion inhibitor, for drug-resistant HIV infection in North and South America","volume":"348","author":"Lalezari","year":"2003","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.micinf.2024.105366_bib9","doi-asserted-by":"crossref","first-page":"9770","DOI":"10.1073\/pnas.91.21.9770","article-title":"Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection","volume":"91","author":"Wild","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2024.105366_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/v11080705","article-title":"Development of protein- and peptide-based HIV entry inhibitors targeting gp120 or gp41","volume":"11","author":"Pu","year":"2019","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2024.105366_bib11","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0092-8674(00)80205-6","article-title":"Core structure of gp41 from the HIV envelope glycoprotein","volume":"89","author":"Chan","year":"1997","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2024.105366_bib12","doi-asserted-by":"crossref","first-page":"6759","DOI":"10.1093\/jac\/dku183","article-title":"The M-T hook structure increases the potency of HIV-1 fusion inhibitor sifuvirtide and overcomes drug resistance","volume":"69","author":"Chong","year":"2014","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.micinf.2024.105366_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1742-4690-11-40","article-title":"Two M-T hook residues greatly improve the antiviral activity and resistance profile of the HIV-1 fusion inhibitor SC29EK","volume":"11","author":"Chong","year":"2014","journal-title":"Retrovirology"},{"key":"10.1016\/j.micinf.2024.105366_bib14","doi-asserted-by":"crossref","first-page":"34558","DOI":"10.1074\/jbc.M112.390393","article-title":"The M-T hook structure is critical for design of HIV-1 fusion inhibitors","volume":"287","author":"Chong","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2024.105366_bib15","doi-asserted-by":"crossref","first-page":"20281","DOI":"10.1074\/jbc.M112.354126","article-title":"Discovery of critical residues for viral entry and inhibition through structural Insight of HIV-1 fusion inhibitor CP621-652","volume":"287","author":"Chong","year":"2012","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2024.105366_bib16","doi-asserted-by":"crossref","first-page":"6378","DOI":"10.1021\/acs.jmedchem.5b00109","article-title":"The N-terminal T-T motif of a third-generation HIV-1 fusion inhibitor is not required for binding affinity and antiviral activity","volume":"58","author":"Chong","year":"2015","journal-title":"J\u00a0Med Chem"},{"key":"10.1016\/j.micinf.2024.105366_bib17","doi-asserted-by":"crossref","first-page":"16332","DOI":"10.1073\/pnas.0807335105","article-title":"Potent HIV fusion inhibitors against Enfuvirtide-resistant HIV-1 strains","volume":"105","author":"He","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2024.105366_bib18","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1096\/fj.12-222547","article-title":"Short-peptide fusion inhibitors with high potency against wild-type and enfuvirtide-resistant HIV-1","volume":"27","author":"Chong","year":"2013","journal-title":"Faseb J"},{"key":"10.1016\/j.micinf.2024.105366_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/QAD.0000000000000498","article-title":"Design of a highly potent HIV-1 fusion inhibitor targeting the gp41 pocket","volume":"29","author":"Chong","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/j.micinf.2024.105366_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01839-16","article-title":"A\u00a0helical short-peptide fusion inhibitor with highly potent activity against human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus","volume":"91","author":"Xiong","year":"2017","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/QAD.0000000000001073","article-title":"Development of potent and long-acting HIV-1 fusion inhibitors","volume":"30","author":"Chong","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/j.micinf.2024.105366_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00288-17","article-title":"A\u00a0lipopeptide HIV-1\/2 fusion inhibitor with highly potent in\u00a0vitro, ex\u00a0vivo, and in\u00a0vivo antiviral activity","volume":"91","author":"Chong","year":"2017","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1007552","article-title":"Monotherapy with a low-dose lipopeptide HIV fusion inhibitor maintains long-term viral suppression in rhesus macaques","volume":"15","author":"Chong","year":"2019","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.micinf.2024.105366_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cell.2021.11.032","article-title":"Efficient treatment and pre-exposure prophylaxis in rhesus macaques by an HIV fusion-inhibitory lipopeptide","volume":"185","author":"Xue","year":"2022","journal-title":"Cell"},{"key":"10.1016\/j.micinf.2024.105366_bib25","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01088-18","article-title":"Structural and functional characterization of membrane fusion inhibitors with extremely potent activity against HIV-1, HIV-2, and simian immunodeficiency virus","volume":"92","author":"Chong","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00775-18","article-title":"Design of novel HIV-1\/2 fusion inhibitors with high therapeutic efficacy in rhesus monkey models","volume":"92","author":"Chong","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib27","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02312-18","article-title":"Design and characterization of cholesterylated peptide HIV-1\/2 fusion inhibitors with extremely potent and long-lasting antiviral activity","volume":"93","author":"Zhu","year":"2019","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/jac\/dkh330","article-title":"Resistance to enfuvirtide, the first HIV fusion inhibitor","volume":"54","author":"Greenberg","year":"2004","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.micinf.2024.105366_bib29","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1097\/00002030-200409030-00007","article-title":"Characterization of determinants of genotypic and phenotypic resistance to enfuvirtide in baseline and on-treatment HIV-1 isolates","volume":"18","author":"Sista","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.micinf.2024.105366_bib30","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1128\/JVI.79.8.4774-4781.2005","article-title":"Human immunodeficiency virus (HIV) gp41 escape mutants: cross-resistance to peptide inhibitors of HIV fusion and altered receptor activation of gp120","volume":"79","author":"Desmezieres","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib31","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1128\/AAC.49.3.1113-1119.2005","article-title":"Emergence and evolution of enfuvirtide resistance following long-term therapy involves heptad repeat 2 mutations within gp41","volume":"49","author":"Xu","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.micinf.2024.105366_bib32","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.3390\/v2051069","article-title":"HIV-1 entry, inhibitors, and resistance","volume":"2","author":"Lobritz","year":"2010","journal-title":"Viruses"},{"key":"10.1016\/j.micinf.2024.105366_bib33","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/427993","article-title":"T-1249 retains potent antiretroviral activity in patients who had experienced virological failure while on an enfuvirtide-containing treatment regimen","volume":"191","author":"Lalezari","year":"2005","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2024.105366_bib34","doi-asserted-by":"crossref","first-page":"12772","DOI":"10.1073\/pnas.0701478104","article-title":"Design of helical, oligomeric HIV-1 fusion inhibitor peptides with potent activity against enfuvirtide-resistant virus","volume":"104","author":"Dwyer","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2024.105366_bib35","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.1002\/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J","article-title":"Remodeling of gp41-C34 peptide leads to highly effective inhibitors of the fusion of HIV-1 with target cells","volume":"41","author":"Otaka","year":"2002","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.micinf.2024.105366_bib36","doi-asserted-by":"crossref","first-page":"11126","DOI":"10.1074\/jbc.M800200200","article-title":"Design and evaluation of sifuvirtide, a novel HIV-1 fusion inhibitor","volume":"283","author":"He","year":"2008","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2024.105366_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0032599","article-title":"Biophysical property and broad anti-HIV activity of albuvirtide, a 3-maleimimidopropionic acid-modified peptide fusion inhibitor","volume":"7","author":"Chong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.micinf.2024.105366_bib38","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1073\/pnas.0901007106","article-title":"Addition of a cholesterol group to an HIV-1 peptide fusion inhibitor dramatically increases its antiviral potency","volume":"106","author":"Ingallinella","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.micinf.2024.105366_bib39","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00831-17","article-title":"Enfuvirtide (T20)-based lipopeptide is a potent HIV-1 cell fusion inhibitor: implication for viral entry and inhibition","volume":"91","author":"Ding","year":"2017","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib40","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00384-20","article-title":"Therapeutic efficacy and resistance selection of a lipopeptide fusion inhibitor in simian immunodeficiency virus-infected rhesus macaques","volume":"94","author":"Yu","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib41","doi-asserted-by":"crossref","first-page":"12703","DOI":"10.1074\/jbc.RA118.003538","article-title":"Molecular mechanism of HIV-1 resistance to sifuvirtide, a clinical trial-approved membrane fusion inhibitor","volume":"293","author":"Yu","year":"2018","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.micinf.2024.105366_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02044-17","article-title":"Mechanism of HIV-1 resistance to an electronically constrained alpha-helical peptide membrane fusion inhibitor","volume":"92","author":"Wu","year":"2018","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib43","doi-asserted-by":"crossref","first-page":"12467","DOI":"10.1128\/JVI.01741-15","article-title":"Genetic pathway of HIV-1 resistance to novel fusion inhibitors targeting the Gp41 pocket","volume":"89","author":"Su","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib44","doi-asserted-by":"crossref","first-page":"5801","DOI":"10.1128\/JVI.00373-15","article-title":"Mechanism of HIV-1 resistance to short-peptide fusion inhibitors targeting the Gp41 pocket","volume":"89","author":"Su","year":"2015","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2024.105366_bib45","article-title":"In\u00a0vitro selection and characterization of HIV-1 variants with increased resistance to LP-40, enfuvirtide-based lipopeptide inhibitor","volume":"23","author":"Hu","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.micinf.2024.105366_bib46","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bbrc.2012.06.097","article-title":"A\u00a0simple, rapid, and sensitive system for the evaluation of anti-viral drugs in rats","volume":"424","author":"Li","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.micinf.2024.105366_bib47","article-title":"The tryptophan-rich motif of HIV-1 gp41 can interact with the N-terminal deep pocket site: new insights into the structure and function of gp41 and its inhibitors","volume":"94","author":"Zhu","year":"2020","journal-title":"J\u00a0Virol"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457924001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457924001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T23:04:29Z","timestamp":1778799869000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457924001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":47,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1286457924001023"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2024.105366","relation":{},"ISSN":["1286-4579"],"issn-type":[{"value":"1286-4579","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of novel HIV fusion-inhibitory lipopeptides with the M-T hook structure","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2024.105366","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"105366"}}